Elsy Boglioli joined the Board of Directors of FTI Consulting, Inc. in April 2023 and serves as a member of the Audit Committee and the Nominating, Corporate Governance and Social Responsibility Committee.
Ms. Boglioli founded and has been the Chief Executive Officer of Bio-Up, a consulting firm providing advisory services to companies in the healthcare technology field, since September 2019.
From December 2017 to August 2019, Ms. Boglioli served as Executive Vice President and Chief Operating Officer of Cellectis, a clinical-stage biopharmaceutical company focusing on cell therapies, where her responsibilities included directing the Company’s long-term strategy and business priorities. From January 2006 to November 2017, Ms. Boglioli was employed by the Boston Consulting Group, holding various positions, most recently as a Partner and Managing Director, as well as leader of its biotech-focused business in Europe and as a member of its global Strategy and Biopharma practice leadership teams.
Ms. Boglioli serves as a member of the Board of Directors of GenSight Biologics S.A., a French publicly held biopharma company focusing on gene therapies, since October 2020, and serves as Chair of the Nomination Committee. Ms. Boglioli also serves as a member of the Board of Directors of OSE Immunotherapeutics S.A., a French publicly held clinical-stage biotechnology company focused on immunotherapies, since July 2021, and is a member of its Nomination and Remuneration Committee. She is also the Chair of the Board of Directors of TreeFrog Therapeutics, a privately held biotechnology company focused on expanding access to cell therapies, and is a member of the Boards of Directors of other privately held companies in the healthcare technologies field: Inova.io, Laverock Therapeutics, Metafora Biosystems and Womed Tech.
Ms. Boglioli was selected as a Young Leader of the French American Foundation in 2018, was part of the Choiseul ranking of top Young French Economic Leaders in 2019 and 2020, and was among the Women’s Forum Rising Talents’ promotion of 2018.
Ms. Boglioli graduated from École Polytechnique in Paris, France, and holds a master’s degree in economy and management from the Pompeu Fabra University in Barcelona, Spain, and a college degree in immuno-oncology from Institut Gustave Roussy in Paris, France.